Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Q1 financials B4 May 16 and "Special Meeting" proxy?

<< Previous

Bullboard Posts

Next >>

Comment by PezDalatoYouon Apr 26, 2021 4:07pm

130 Views

Post# 33068607

RE:Q1 financials B4 May 16 and "Special Meeting" proxy?

The share consolidation stinks, IMO. While I'm busy flapping my arms, a mild amount of self promotion by the company could get the share price up well beyond Nasdaq listing requirements. We could already be there. And they were talking share buyback just a few years ago. Sheesh.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security